The association between p53 and the beneficial effects exerted by resveratrol in cancer were further explored and evaluated by the genetic alterations in 3 overlapping genes (PTEN, TP53 and CDKN1A) revealed by resveratrol associated p53 signaling and prostate cancer pathways (Table 3). This evidence concerns the gene CDKN1A and prostate cancer.